Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Free Cash Flow (2016 - 2026)

Kewaunee Scientific (KEQU) has 16 years of Free Cash Flow data on record, last reported at -$5.8 million in Q4 2025.

  • For Q4 2025, Free Cash Flow fell 175.26% year-over-year to -$5.8 million; the TTM value through Oct 2025 reached $5.1 million, down 67.74%, while the annual FY2025 figure was $12.6 million, 16.94% down from the prior year.
  • Free Cash Flow reached -$5.8 million in Q4 2025 per KEQU's latest filing, down from $5.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $9.0 million in Q1 2024 and bottomed at -$7.5 million in Q2 2022.
  • Average Free Cash Flow over 5 years is $479250.0, with a median of -$795000.0 recorded in 2023.
  • Peak YoY movement for Free Cash Flow: crashed 299.03% in 2021, then surged 5256.02% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$4.7 million in 2021, then dropped by 1.24% to -$4.8 million in 2022, then soared by 89.21% to -$518000.0 in 2023, then surged by 1596.72% to $7.8 million in 2024, then tumbled by 175.26% to -$5.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were -$5.8 million in Q4 2025, $5.0 million in Q3 2025, and $8.9 million in Q2 2025.